← Back to Search

Diagnostic (biospecimen collection) for Prostate Cancer

N/A
Recruiting
Led By Jonathan Katz, Ph.D.
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group

Summary

This pilot research trial utilizes the collection of blood in studying metabolites in patients with prostate cancer. Metabolites are the small molecule products of cellular metabolism that are produced naturally in all living cells. Collecting blood in order to study metabolites may help doctors monitor and treat prostate cancer more effectively.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Blood sample collection

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Diagnostic (biospecimen collection)Experimental Treatment2 Interventions
Patients undergo collection of blood for metabolic profiling via LC/Q-TOF/MS.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection
2004
Completed Phase 3
~2020

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor
942 Previous Clinical Trials
1,604,588 Total Patients Enrolled
17 Trials studying Prostate Cancer
9,412 Patients Enrolled for Prostate Cancer
National Cancer Institute (NCI)NIH
13,887 Previous Clinical Trials
41,021,003 Total Patients Enrolled
568 Trials studying Prostate Cancer
529,850 Patients Enrolled for Prostate Cancer
Jonathan Katz, Ph.D.Principal InvestigatorUniversity of Southern California
~1 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top